TeleMAb Retrospective Cohort Study

The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Medication Abortion Telemedicine

Sex eligibility

Female

Study type

Observational

Primary location

Columbia University Irving Medical Center

New York, 10032-3720, United States

About this study

This study will be retrospective chart review comparing clinical and demographic characteristics, eligibility, treatment success, participation in unscheduled and scheduled follow-ups, and adverse events of patients who obtained a telemedicine medication abortion through the Telehealth Medication Abortion Clinic with patients who received an in-person medication abortion provided at the Family Planning Faculty Practice from June 2023 through September 2024.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Received telemedicine or in-person medication abortion at Columbia University Irving Medical Center's associated practices from June 12, 2023 through September 30, 2024
Gestational age <70 days (based on best obstetrical dating)
English or Spanish speaking

Exclusion criteria

Received mifepristone and misoprostol for early pregnancy loss
Patient determined to have contraindication to medication abortion
Opted for procedural management instead of medication abortion
Decided to continue with the pregnancy
Presenting for a second medication abortion at CUIMC during the study period
Non-English or Spanish speaking

Treatment and study plan

Telemedicine Medication Abortion

Other

Meeting with a clinician via video visit to determine if patient is eligible for medication abortion without pre-treatment ultrasound or laboratory testing. If eligible, the patient travels to clinic to pick up medications in person.

Primary outcomes

Number of unscheduled follow-ups

Time frame: 3 months after initial encounter

If patients engaged in follow-up are outside of their routinely scheduled follow-up visit 1-2 weeks after medication abortion

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Registry information

Official study title

A Retrospective Cohort Study Comparing Clinical Outcomes and Unscheduled Follow-up of Telemedicine and In-person Medication Abortion

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2026
First posted: Feb 12, 2026
Registry last updated: Feb 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed